Literature DB >> 11138623

Eosinophil granule proteins and their role in disease.

G M Walsh1.   

Abstract

The eosinophil has a potent armory of proinflammatory mediators with considerable potential to initiate and sustain an inflammatory response. These include cytotoxic granule proteins, cytokines, chemokines, and lipid mediators. Eosinophils are considered important in the immune response to infection with helminthic parasitic worms. Incrementally increasing evidence supports a critical role for their proinflammatory activities in diverse human conditions, most notably in allergic diseases such as asthma. In these conditions severe tissue damage is a consequence of an inappropriate accumulation of eosinophils and the subsequent release of their highly toxic granule proteins. In addition, release of granule-associated products such as chemokines and cytokines at the sites of inflammation is likely to have significant paracrine and autocrine relevance. This review will update recent developments in understanding the role that eosinophil granule proteins play in human disease, particularly those of the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11138623     DOI: 10.1097/00062752-200101000-00006

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  27 in total

1.  CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice.

Authors:  Steve D Swain; Nicole N Meissner; Allen G Harmsen
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Multiple brain infarctions induced by imatinib mesylate in a patient with clonal eosinophilia.

Authors:  Eriko Sato; Koichi Sugimoto; Yasuharu Hamano; Yasushi Isobe; Makoto Sasaki; Junichi Tomomatsu; Hideaki Nitta; Kazuo Oshimi
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

3.  Antimicrobial Activity of Human Eosinophil Granule Proteins.

Authors:  Anu Chopra; Janendra K Batra
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.

Authors:  Vivekanandhan Aravindhan; Gowrishankar Anand
Journal:  Am J Trop Med Hyg       Date:  2017-10-26       Impact factor: 2.345

5.  Heightened Systemic Levels of Neutrophil and Eosinophil Granular Proteins in Pulmonary Tuberculosis and Reversal following Treatment.

Authors:  Kadar Moideen; Nathella Pavan Kumar; Dina Nair; Vaithilingam V Banurekha; Ramalingam Bethunaickan; Subash Babu
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

6.  Beta2-integrin-mediated adhesion and intracellular Ca2+ release in human eosinophils.

Authors:  Jennifer L Bankers-Fulbright; Kathleen R Bartemes; Gail M Kephart; Hirohito Kita; Scott M O'Grady
Journal:  J Membr Biol       Date:  2009-03-17       Impact factor: 1.843

7.  Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b.

Authors:  Juhan Yoon; Jens U Ponikau; Christopher B Lawrence; Hirohito Kita
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 8.  Eosinophils in vasculitis: characteristics and roles in pathogenesis.

Authors:  Paneez Khoury; Peter C Grayson; Amy D Klion
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

9.  Regulation of the Il4 gene is independently controlled by proximal and distal 3' enhancers in mast cells and basophils.

Authors:  Ryouji Yagi; Shinya Tanaka; Yasutaka Motomura; Masato Kubo
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

10.  TNF-alpha mediates eosinophil cationic protein-induced apoptosis in BEAS-2B cells.

Authors:  Kun-Che Chang; Chih-Wei Lo; Tan-Chi Fan; Margaret Dah-Tsyr Chang; Chih-Wen Shu; Chuan-Hsin Chang; Cheng-Ta Chung; Shun-Lung Fang; Chih-Chung Chao; Jaw-Ji Tsai; Yiu-Kay Lai
Journal:  BMC Cell Biol       Date:  2010-01-20       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.